首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤标记物在肺癌化疗中的应用
引用本文:马淑萍,秦建文,周静敏,卢金玲. 肿瘤标记物在肺癌化疗中的应用[J]. 中国肿瘤临床, 2005, 32(10): 568-570
作者姓名:马淑萍  秦建文  周静敏  卢金玲
作者单位:天津市胸科医院胸内科,天津市,300051
摘    要:目的:探讨肿瘤标记物变化在肺癌患者化疗效果评价中的应用价值.方法:应用电化学发光免疫分析法检测98例肺癌患者化疗前后CEA、CYFRA21-1、NSE的浓度.结果:腺癌组PR患者化疗前后CEA显著降低,PD患者明显升高(P<0.05),NC患者无显著性差异(P>0.05).鳞癌组PR患者CYFRA21-1显著降低(P<0.05),PD和NC患者无显著性差异(P>0.05).小细胞肺癌组NSE在PR患者显著降低(P<0.05),PD和NC患者无显著差异(P>0.05).结论:监测化疗前后肿瘤标记物CEA、CYFRA21-1、NSE的变化对评价肺癌化疗效果具有一定的应用价值.

关 键 词:肺癌  肿瘤标记物  化疗
文章编号:1000-8179(2005)10-0568-03

Clinical Evaluation of Tumor Markers in Chemotherapy on Lung Cancer
Ma Shuping Qin Jianwen Zhou Jingmin et al. Clinical Evaluation of Tumor Markers in Chemotherapy on Lung Cancer[J]. Chinese Journal of Clinical Oncology, 2005, 32(10): 568-570
Authors:Ma Shuping Qin Jianwen Zhou Jingmin et al
Affiliation:Ma Shuping Qin Jianwen Zhou Jingmin et alDepartment of Thoracic Medicine,Tianjin Chest Hospital,Tianjin
Abstract:Objective: To discuss the value of application for the change of tumor markers in evaluation of the effect of chemotherapy on lung cancer. Methods: CYFRA21-1, CEA and NSE were tested by eletro-chemiluminescence immunoassay in the patients with lung cancer before and after chemotherapy. Results: The value of adenocarcinoma CEA, squamous cell carcinoma CYFRA21-1 and of small cell lung cancer NSE in the PR group were lower compared to that before chemotherapy (P<0.05). In the PD group with adenocarcinoma, the value of CEA increased (P<0.05). In the NC group, there was no significant difference before and after chemotherapy (P>0.05). Conclusion:Monitoring on the change of tumor marker CEA, CYFRA21-1 and NSE before and after chemotherapy will be beneficial for evaluation of the effect of chemotherapy on lung cancer.
Keywords:Lung cancer Tumor marker Chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号